Targeting autocrine amphiregulin robustly and reproducibly inhibits ovarian cancer in a syngeneic model: roles for wildtype p53.
Ovarian cancer (OvCA) remains one of the most devastating malignancies, but treatment options are...
Read More
Hematology/Oncology
Cisatracurium inhibits the growth and induces apoptosis of ovarian cancer cells by promoting lincRNA-p21.
As a common muscle relaxant, cisatracurium has shown good antitumor effect on some tumors. Recent...
Read More
Effect of COVID-19 on Breast Cancer Treatment Examined
MONDAY, May 3, 2021 (HealthDay News) — More patients with estrogen receptor (ER)-positive,...
Read More
Cryoablation Promising for Early Breast Cancer
MONDAY, May 3, 2021 (HealthDay News) — Cryoablation seems promising for early breast cancer...
Read More
Fertility Concerns Impact Treatment Decisions in Breast Cancer
FRIDAY, April 30, 2021 (HealthDay News) — Fertility concerns impact decision-making about...
Read More
Occult Brain Mets Detected in Patients With Advanced Renal Cancer
MONDAY, May 3, 2021 (HealthDay News) — Occult brain metastasis is identified in about 4...
Read More
Mortality Risk Up for Fragmented Care After Complex Cancer Surgery
MONDAY, May 3, 2021 (HealthDay News) — Travel distance and timing contribute to care...
Read More
Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO-16A/MaNGO-OV2A study.
To explore the clinical and biological prognostic factors for advanced ovarian cancer patients...
Read More
ONC201 induces the unfolded protein response (UPR) in high- and low-grade ovarian carcinoma cell lines and leads to cell death regardless of platinum sensitivity.
Treatment of both platinum resistant high grade (HG) and low-grade (LG) ovarian cancer (OVCA)...
Read More
Platinum-based Chemotherapy and Bevacizumab Instigate the Destruction of Human Ovarian Cancers via Different Signaling Pathways.
The standard chemotherapy regimens of ovarian cancer are platinum-based chemotherapy (carboplatin...
Read More
Urinary Incontinence Surgery in Women Not Tied to Pelvic Cancer
THURSDAY, April 29, 2021 (HealthDay News) — Stress urinary incontinence surgery, with or...
Read More
Safety, Efficacy of Vadadustat Explored for CKD
THURSDAY, April 29, 2021 (HealthDay News) — Vadadustat met the noninferiority criteria for...
Read More
Safety, Efficacy of Vadadustat Explored for CKD
THURSDAY, April 29, 2021 (HealthDay News) — Vadadustat met the noninferiority criteria for...
Read More
FDA Poised to Ban Menthol Cigarettes
THURSDAY, April 29, 2021 (HealthDay News) — The U.S. Food and Drug Administration on...
Read More
White House to Propose Menthol Cigarette Ban
WEDNESDAY, April 28, 2021 (HealthDay News) — A proposed ban on menthol cigarettes is...
Read More
PAX8 and MECOM are interaction partners driving ovarian cancer.
The transcription factor PAX8 is critical for the development of the thyroid and urogenital...
Read More
IGF-1R anti-idiotypic antibody antagonist exhibited anti-ovarian cancer bioactivity and reduced cisplatin resistance.
Ovarian cancer is the most deadly gynecological malignant tumor in the world today. Previous...
Read More
Development of a high payload, cancer-targeting liposomes of methyl aminolevulinate for intraoperative photodynamic diagnosis/therapy of peritoneal carcinomatosis.
Methyl aminolevulinate (MAL) is a photosensitizer topically used for photodynamic diagnosis (PDD)...
Read More
Exposure to Secondhand Smoke May Raise Risk for Oral Cancer
WEDNESDAY, April 28, 2021 (HealthDay News) — There seems to be a causal association between...
Read More
Increasing BMI Ups Risk for Second Cancer After Breast Cancer
TUESDAY, April 27, 2021 (HealthDay News) — For women with incident breast cancer, the risk...
Read More